fenoldopam has been researched along with Body Weight in 4 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of chronic oral fenoldopam in the treatment of NYHA grade II-III heart failure secondary to ischaemic heart disease, were studied in a placebo controlled, double blind, randomised, parallel group fashion in 20 patients." | 5.06 | A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease. ( Jeffrey, RF; Lee, MR; MacDonald, TM; Muir, AL, 1990) |
| "Fenoldopam is a direct-acting vasodilator that acts at the postsynaptic dopamine 1 receptors in renal, coronary, cerebral, and splanchnic vasculature resulting in arterial dilation and a lowering of the mean arterial pressure (MAP)." | 2.40 | Initial experience with fenoldopam in children. ( Pruitt, RD; Strauser, LM; Tobias, JD, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, PK | 1 |
| Mukherjee, K | 1 |
| Sahai, A | 1 |
| Strauser, LM | 1 |
| Pruitt, RD | 1 |
| Tobias, JD | 1 |
| MacDonald, TM | 1 |
| Jeffrey, RF | 1 |
| Muir, AL | 1 |
| Lee, MR | 1 |
| Brooks, DP | 1 |
| Drutz, DJ | 1 |
| Ruffolo, RR | 1 |
1 review available for fenoldopam and Body Weight
| Article | Year |
|---|---|
Initial experience with fenoldopam in children.
Topics: Age Factors; Antihypertensive Agents; Body Weight; Brain Neoplasms; Child; Dopamine Agonists; Emerge | 1999 |
1 trial available for fenoldopam and Body Weight
| Article | Year |
|---|---|
A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aged; Body Weight; Coronary Disease; Dop | 1990 |
2 other studies available for fenoldopam and Body Weight
| Article | Year |
|---|---|
Renal dopamine receptors are involved in the development of cardiac hypertrophy.
Topics: Animals; Benzazepines; Body Weight; Cardiomegaly; Dopamine; Fenoldopam; Male; Organ Size; Rats; Rats | 1995 |
Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Body Weight; Cyclosporins; Feno | 1990 |